期刊文献+

造血干细胞移植术后以截瘫为主要表现的神经系统合并症 被引量:1

Neurological Complications with Paraplegia as Main Manifestation after Hematopoietic Stem Cell Transplantation
原文传递
导出
摘要 目的:探讨造血干细胞移植术后出现以截瘫为主要表现的神经系统合并症的病因、诊断和治疗方法。方法:总结自2014年1月至2017年1月在我院血液科接受造血干细胞移植治疗后出现以截瘫为主要表现的神经系统合并症9例的临床特点,诊疗经过以及预后随访。结果:截瘫的发病率为2.96%(9/304),中位发病时间为移植后245(50-772)d,完善检查后确定截瘫病因,3例为白血病髓外复发累及脊髓,1例为环孢素神经毒性,1例为格林-巴利综合征(GBS),2例为慢性炎症脱髓鞘性多神经病(CIDP),2例为自身免疫性脊髓病变。除1例患者放弃治疗外,其余8例患者均接受经验性或针对性治疗,中位随访时间为11个月,死亡5例,存活4例。结论:截瘫是HSCT术后严重的并发症,应尽早明确病因后针对性治疗,必要时可予以经验性抢先治疗,以改善HSCT患者的生存率及生活质量。 Objective:To investigate the cause,diagnosis and therapeutic method of the neurological complication with the main manifestation of paraplegia after the hematopoietic stem cell transplantation(HSCT).Methods:The clinical features,the process of diagnosis and treatment and the prognosis follow-up of 9 cases,who received HSCT in our department during January 2014 and January 2017 and had the neurological complication with the main symptom of paraplegia after the transplantation,were summarized.Results:The incidence rate of paraplegia was 2.96%(9/304).The median onset time was 245 days(50 days-772 days)after transplantation.The cause of paraplegia determined by examination was extramedullary recurrence of leukemia in 3 cases,cyclosporin neurotoxicity in 1 case,GBS in1 case,CIDP in 2 cases and autoimmune myeleterosis in 2 cases.One patient abandoned the treatment.The rest 8 patients received empirical or targeted treatment.The median follow-up period was 11 months.There were 5 dead cases and 4 survival cases.Conclusion:Paraplegia is a serious post-HSCT complication.The cause of paraplegia should be determined as early as possible to perform targeted treatment.Empirical preemptive treatment should be given if necessary,so as to improve the survival rate and the quality of life of HSCT patients.
作者 薛松 张永平 张书芹 肖天祎 徐依成 崔斌 王静波 XUE Song;ZHANG Yong-Ping;ZHANG Shu-Qin;XIAO Tian-Yi;XU Yi-Cheng;CUI Bin;WANG Jing-Bo(Department of Hematology,Aerospace Center Hospital,Beijing 100049,China;Department of Neurology,Aerospace Center Hospital,Beijing 100049,China;Department of Radiology,Aerospace Center Hospital,Beijing 100049,China)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2020年第2期595-601,共7页 Journal of Experimental Hematology
关键词 截瘫 造血干细胞移植 神经系统 并发症 paraplegia hematopoietic stem cell transplantation nervous system complications
  • 相关文献

参考文献10

二级参考文献102

  • 1钟春玖,费国强,金莉蓉.颅脑MRI检查在非乙醇中毒性韦尼克脑病诊断中的价值[J].临床神经病学杂志,2005,18(2):100-102. 被引量:37
  • 2王恒湘,纪树荃,朱玲,刘静,薛梅,丁丽,段连宁,阎洪敏,陈惠仁.单倍相合骨髓移植术后中枢神经系统并发症[J].中国实验血液学杂志,2005,13(6):1128-1130. 被引量:2
  • 3Nordal RA, Wong CS. Molecular targets in radiation induced blood-brain barrier disruption. Int J Radiat Oncol Biol Phys, 2005, 62:279-287.
  • 4Porkka K, Koskenvesa P, Lundan T, et al. Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia. Blood, 2008, 112 : 1005-1012.
  • 5Cunha BA. Central nervous system infections in the compromised host: a diagnostic approach. Infect Dis Clin North Am, 2001,15: 567-590.
  • 6Bartynski WS, Zeigler ZR, Shadduck RK, et al. Pretransplantafion conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol, 2004,25:261-269.
  • 7Pasquini M. Report on state of the art in blood and marrow transplantation-CIBMTR summary slides Part I 2005 [J].CIBMTR Newsletter, 2006,12 ( 1 ) : 5-8.
  • 8BekassyA N, Hermans J , Gorin N C, et al. Granulocytic sarcoma after allogeneic bone marrow transplantation: a ret2 rospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation[J]. Bone Marrow Transplant, 1996,17(5) :801-808.
  • 9Lee J H, Choi S J. Anti-leukemic effect of graftversus-host disease on bone marrow and extramedullary relapses in acute leukemia [J]. Haematologica, 2005,90(10) : 1380-1388.
  • 10Lee K H, Lee J H, Choi S J, et al. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietie cell transplantation: risk factors and clinical course [ J ]. Bone Marrow Transplant, 2003,32 (8) : 835-842.

共引文献29

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部